[Infectious Disease Reports 2013; 5:s1e7] [page 31]

Around 33 million people worldwide are liv-ing with Human Immunodeficiency Virus (HIV) infection, and approximately 20-30 % of HIV-infected individuals are also infected with Hepatitis C virus (HCV). The main form of HCV transmission is via the blood borne route; high rates of co-infection are found in intra-venous drug users with HCV prevalence rates as high as 90%. Introduction of effective anti-retroviral therapy (ART) has led to a signifi-cant decline in HIV-related morbidity, but at the same time the incidence of HCV related liver disease is increasing in the co-infecte